Daniel D. Long sold $533K of Septerna (SEPN)

Executed Jun 22, disclosed Jun 24, 2 days later.

Value, as filed

$533K

15,000 sh across 2 lots

Executed

Jun 22

the trade date, as filed

Disclosed

Jun 24

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Daniel D. Long SVP, Drug Discovery profile →

Daniel D. Long (SVP, Drug Discovery) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Septerna, Inc. (SEPN). The largest single filing was $533K of SEPN (15,000 sh across 2 lots, as filed), executed Jun 22.

The name

SEPN

Septerna, Inc. SEPN · Healthcare · 13 filings in 24 months ticker →

Healthcare · Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule produc…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Daniel D. Long in SEPN

SEPNSALE Septerna, Inc. $126K
3,333 sh × $37.83
Exec Sep 1
Filed Sep 3 · 7:01 PM ET